Earnings & Financial Performance
Titan America (TTAM) posted record full‐year 2024 results with revenue of $1.63 billion and net income of $166.1 million, setting a robust benchmark despite Q4 challenges.
Chewy (CHWY) reported fiscal Q4 net sales of $3.25 billion and improved profitability driven by its loyal customer base.
Paychex (PAYX) delivered a strong third‐quarter performance with total revenue reaching $1.5 billion and EPS climbing 4% to $1.43, underscoring steady operational momentum.
PayPal (PYPL) surpassed a key milestone by exceeding $30 billion in global small business loan originations, reinforcing its leadership in fintech lending.
Concentrix (CNXC) reported Q1 2025 financials with revenue of $2.37 billion (up 1.3% on a constant currency basis) and operating income of $168.9 million, along with plans to return over $240 million to shareholders. Read more in their detailed update.
TAT Technologies (TATT) delivered strong full‐year 2024 performance with revenue up 34% to $152.1 million and net income surging 139% to $11.2 million ($1.0 per diluted share). The firm also grew its gross profit to $33 million (21.7% of revenue) and increased Adjusted EBITDA by 67% to $18.6 million. New contracts worth $47 million in Q4 pushed its backlog to a record $429 million, marking nine consecutive quarters of revenue growth. Full details are available in their official announcement.
Envela (ELA) delivered its Q4 and FY2024 results with annual revenue of $180.4 million and bolstered liquidity through a record net cash position and an expanded retail footprint. The complete financial update is available here.
Corporate & Strategic Moves
Global Net Lease (GNL) successfully completed the first phase of its multi‐tenant portfolio sale, raising roughly $1.1 billion and highlighting robust asset performance in retail real estate.
Rivian (RIVN) spun out its micromobility business into a new venture, securing a $105 million investment while retaining a significant stake to focus on its core electric vehicle operations.
TotalEnergies (TTE) faces official investigations into alleged human rights abuses linked to its Mozambique LNG project, intensifying regulatory scrutiny.
GameStop (GME) announced a proposed private offering of $1.3 billion in Convertible Senior Notes due 2030, aimed at supporting its evolving business model, including potential Bitcoin acquisition strategies.
VICI Properties (VICI) priced a public offering of $1.3 billion in senior unsecured notes, with proceeds designated for debt repayment and general corporate purposes. Full offering details are available here.
California American Water (AWK) is set to invest over $1.5 billion over the next decade in upgrading water and wastewater infrastructure across the state, following concerning grades in the ASCE 2025 Report Card. The company’s President emphasized the need for significant capital investments amidst climate and system challenges. More details can be found in the full report.
TransAlta Corporation (TAC) has launched an Automatic Share Purchase Plan under its existing Normal Course Issuer Bid, allowing the purchase of up to 14,000,000 common shares between May 31, 2024, and May 30, 2025. The plan facilitates share repurchases during typically restricted periods. Additional information is available here.
Biotech & Healthcare Innovations
Merck (MRK) secured European Commission approval for its CAPVAXIVE® 21‐valent vaccine to combat invasive pneumococcal disease in adults, reinforcing its commitment to global health solutions.
Johnson & Johnson (JNJ) announced Phase 3 MARIPOSA study results, demonstrating that the RYBREVANT® plus LAZCLUZE™ combination extends overall survival in patients with EGFR‑mutated non‑small cell lung cancer.
Alcon (ALC) acquired a majority stake in Aurion Biotech to accelerate the progression of its key asset AURN001 into Phase 3 trials, a move aimed at addressing global shortages in corneal tissue. The complete story is available here.
Zepp Health (ZEPP) reported Q4 2024 financial results with revenue reaching US$59.5 million and a robust quarter-over-quarter performance, along with full-year improvements in gross margin and successful refinancing of short-term debt. Further updates are provided in their report.
Soleno Therapeutics (SLNO) received U.S. FDA approval for VYKAT XR, the first therapy approved for treating hyperphagia in patients with Prader-Willi syndrome. The approval, based on Phase 3 trial data, paves the way for the drug’s U.S. launch in April 2025, with details available here.
Technology, Market Trends & Legal Developments
Palo Alto Networks (PANW) secured a multiyear partnership with the NHL to integrate advanced cybersecurity solutions into high‐profile sports platforms, highlighting the expanding role of tech in traditional industries.
JPMorganChase (JPM), in collaboration with leading research institutions, achieved a breakthrough in certified quantum randomness using its 56‑qubit trapped‑ion system—a development that could redefine computational limits for the financial sector. More insights are available in their announcement.
Tilray Brands (TLRY) and its subsidiary HEXO secured a legal victory with the dismissal of an $8 million shareholder lawsuit, marking a significant step in affirming confidence in their corporate governance practices. The court’s decision is detailed here.
